Clinical validation of a 10-color flow cytometry panel to detect measurable residual disease in acute myeloid leukemia.

Competing Interests: Declaration of Competing Interest I certify that (1) the study submitted has not received any financial support from pharmaceutical industry or other commercial source, and (2) neither I, nor any first-degree relative possess any financial interest in the subject approached in the manuscript.